These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


284 related items for PubMed ID: 21438702

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Use of crospovidone as pelletization aid as alternative to microcrystalline cellulose: effects on pellet properties.
    Verheyen P, Steffens KJ, Kleinebudde P.
    Drug Dev Ind Pharm; 2009 Nov; 35(11):1325-32. PubMed ID: 19832632
    [Abstract] [Full Text] [Related]

  • 3. Influence of MCC II fraction and storage conditions on pellet properties.
    Krueger C, Thommes M, Kleinebudde P.
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1039-45. PubMed ID: 23872176
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Evaluation of Ceolus™ microcrystalline cellulose grades for the direct compression of enteric-coated pellets.
    Kucera SU, DiNunzio JC, Kaneko N, McGinity JW.
    Drug Dev Ind Pharm; 2012 Mar; 38(3):341-50. PubMed ID: 21870908
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The influence of non-ionic surfactants on the rheological properties of drug/microcrystalline cellulose/water mixtures and their use in the preparation and drug release performance of pellets prepared by extrusion/spheronization.
    Podczeck F, Maghetti A, Newton JM.
    Eur J Pharm Sci; 2009 Jun 28; 37(3-4):334-40. PubMed ID: 19491024
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Suitability of κ-carrageenan pellets for the formulation of multiparticulate tablets with modified release.
    Ghanam D, Kleinebudde P.
    Int J Pharm; 2011 May 16; 409(1-2):9-18. PubMed ID: 21335073
    [Abstract] [Full Text] [Related]

  • 12. Feasability of a new process to produce fast disintegrating pellets as novel multiparticulate dosage form for pediatric use.
    Hoang Thi TH, Lhafidi S, Carneiro SP, Flament MP.
    Int J Pharm; 2015 Dec 30; 496(2):842-9. PubMed ID: 26403385
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Control of drug release by incorporation of sorbitol or mannitol in microcrystalline-cellulose-based pellets prepared by extrusion-spheronization.
    Goyanes A, Souto C, Martínez-Pacheco R.
    Pharm Dev Technol; 2010 Dec 30; 15(6):626-35. PubMed ID: 20148708
    [Abstract] [Full Text] [Related]

  • 17. Use of kappa-carrageenan as alternative pelletisation aid to microcrystalline cellulose in extrusion/spheronisation. II. Influence of drug and filler type.
    Thommes M, Kleinebudde P.
    Eur J Pharm Biopharm; 2006 May 30; 63(1):68-75. PubMed ID: 16325384
    [Abstract] [Full Text] [Related]

  • 18. Development of multiple-unit pellet system tablets by employing the SeDeM expert diagram system II: pellets containing different active pharmaceutical ingredients.
    Hamman H, Hamman J, Wessels A, Scholtz J, Steenekamp J.
    Pharm Dev Technol; 2019 Feb 30; 24(2):145-156. PubMed ID: 29394129
    [Abstract] [Full Text] [Related]

  • 19. Evaluation of two novel co-processed excipients for direct compression of orodispersible tablets and mini-tablets.
    Kokott M, Lura A, Breitkreutz J, Wiedey R.
    Eur J Pharm Biopharm; 2021 Nov 30; 168():122-130. PubMed ID: 34474110
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 15.